NGM Biopharmaceuticals, Inc. Research and Development Expenses 2019-2023 | NGM
NGM Biopharmaceuticals, Inc. research and development expenses from 2019 to 2023. Research and development expenses can be defined as an expense arising from studies and product development processes.
| NGM Biopharmaceuticals, Inc. Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2023 | $118 |
| 2022 | $181 |
| 2021 | $162 |
| 2020 | $164 |
| 2019 | $129 |
| 2018 | $96 |
| 2017 | $80 |
| NGM Biopharmaceuticals, Inc. Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2023-12-31 | $22 |
| 2023-09-30 | $23 |
| 2023-06-30 | $32 |
| 2023-03-31 | $41 |
| 2022-12-31 | $47 |
| 2022-09-30 | $46 |
| 2022-06-30 | $45 |
| 2022-03-31 | $43 |
| 2021-12-31 | $39 |
| 2021-09-30 | $39 |
| 2021-06-30 | $44 |
| 2021-03-31 | $41 |
| 2020-12-31 | $40 |
| 2020-09-30 | $47 |
| 2020-06-30 | $38 |
| 2020-03-31 | $38 |
| 2019-12-31 | $42 |
| 2019-09-30 | $29 |
| 2019-06-30 | $29 |
| 2019-03-31 | $30 |
| 2018-12-31 | $29 |
| 2018-09-30 | $24 |
| 2018-06-30 | $23 |
| 2018-03-31 | $19 |
